Exact Sciences
EXAS
#1764
Rank
โ‚ฌ8.88 B
Marketcap
47,99ย โ‚ฌ
Share price
-3.29%
Change (1 day)
-13.96%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Exact Sciences (EXAS) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : โ‚ฌ3.24 Billion

According to Exact Sciences's latest financial reports the company's total liabilities are โ‚ฌ3.24 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Exact Sciences - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31โ‚ฌ3.00 B1.37%
2022-12-31โ‚ฌ2.96 B1.94%
2021-12-31โ‚ฌ2.91 B33.15%
2020-12-31โ‚ฌ2.18 B101.16%
2019-12-31โ‚ฌ1.08 B47.5%
2018-12-31โ‚ฌ0.73 B1031.59%
2017-12-31โ‚ฌ65.12 M64.1%
2016-12-31โ‚ฌ39.68 M16.73%
2015-12-31โ‚ฌ33.99 M73.44%
2014-12-31โ‚ฌ19.6 M139.33%
2013-12-31โ‚ฌ8.19 M-19.89%
2012-12-31โ‚ฌ10.22 M-1.34%
2011-12-31โ‚ฌ10.36 M-17.76%
2010-12-31โ‚ฌ12.6 M-8.25%
2009-12-31โ‚ฌ13.73 M130.46%
2008-12-31โ‚ฌ5.95 M4.74%
2007-12-31โ‚ฌ5.68 M-15.75%
2006-12-31โ‚ฌ6.75 M-39.51%
2005-12-31โ‚ฌ11.16 M-16.47%
2004-12-31โ‚ฌ13.36 M-25.07%
2003-12-31โ‚ฌ17.83 M58.84%
2002-12-31โ‚ฌ11.22 M139.92%
2001-12-31โ‚ฌ4.67 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
โ‚ฌ0.32 B-90.10%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ94.9 M-97.08%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ20.33 M-99.37%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ56.71 B 1,647.92%๐Ÿ‡ซ๐Ÿ‡ท France